Portal aids CMO/client communication; Ion technology from Russia;

> An Internet portal from software maker SourceSolution allows CMOs and CROs to securely exchange data, documents and project information with their clients. Release

> A project in Russia aims to develop ophthalmic treatments to be manufactured using Skulachev ion targeted-antioxidant technology. Article

> QRxPharma and China Aoxing are co-developing MoxDuo IV, an intravenous formulation of the former's morphine and oxycodone Dual-Opioid treatment of moderate to severe pain. Release 

> A multi-million dollar federal grant has paved the way for G-Con to start work on a vaccine production plant in Bryan, TX. Item

> California-based generics maker SOHM has allied itself with an injectable manufacturing unit in India, gaining additional capacity for injectable and drops-based products. Announcement


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.